Breast neoplasms Trials in Barcelona, Spain
Conditions / Breast neoplasms / Barcelona, Spain
Research into Breast neoplasms spans multiple therapeutic approaches and trial phases.
57 total trials for this combination
Showing top 10 of 57 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05113251 | Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) | RECRUITING | — |
| NCT04596150 | Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer | COMPLETED | PHASE2 |
| NCT00900627 | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) | COMPLETED | PHASE1/PHASE2 |
| NCT06966453 | A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | RECRUITING | — |
| NCT07038369 | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT03678883 | 9-ING-41 in Patients with Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) | RECRUITING | — |
| NCT06966453 | A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | RECRUITING | — |
| NCT05401643 | Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors | COMPLETED | NA |